| Full text | |
| Author(s): |
Sanches, Paulo R. S.
[1]
;
Charlie-Silva, Ives
[2]
;
Braz, Helyson L. B.
[3]
;
Bittar, Cintia
[4]
;
Calmon, Marilia Freitas
[4]
;
Rahal, Paula
[4]
;
Cilli, Eduardo M.
[1]
Total Authors: 7
|
| Affiliation: | [1] Sao Paulo State Univ, Inst Chem, UNESP, Araraquara, SP - Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, SP - Brazil
[3] Univ Fed Ceara, Dept Morphol, Sch Med, Fortaleza, Ceara - Brazil
[4] Sao Paulo State Univ, Inst Biosci Language & Exact Sci, UNESP, Sao Jose Do Rio Preto, SP - Brazil
Total Affiliations: 4
|
| Document type: | Journal article |
| Source: | JOURNAL OF VIRUS ERADICATION; v. 7, n. 3 SEP 2021. |
| Web of Science Citations: | 0 |
| Abstract | |
New variants of SARS-CoV-2 Alpha (B.1.1.7); Beta (B.1.351) Gamma (P.1) and Delta (B.1.617.2) quickly spread in the UK, South Africa, Brazil and India, respectively. To address whether mutations in SARS-CoV-2 RBD spike protein could affect virus infectivity, peptides containing RBD amino acids mutations have been constructed and interacted with human ACE2 by computational methods. Our results suggest that mutations in RBD amino acids K417, E484, L452, T478 and N501 are expressively increasing the affinity of this protein with human angiotensin-converting enzyme 2 (ACE2), consequently, variants Alpha (B.1.1.7), Beta (B1.351), Gamma (P.1) and Delta (B.1.617.2) could be more infective in human cells compared with SARS-CoV-2 isolated in Wuhan2019 and the Gamma and Delta variants could be the most infective among them. (AU) | |
| FAPESP's process: | 20/12519-4 - Study of the action of synthetic peptides as antivirals against SARS-CoV-2 (COVID-19) and combined evaluation with commercial anti-inflammatories |
| Grantee: | Paulo Ricardo da Silva Sanches |
| Support Opportunities: | Scholarships in Brazil - Post-Doctoral |
| FAPESP's process: | 20/05761-3 - Study of the action of synthetic peptides as antivirals against SARS-CoV-2 (COVID-19) and combined evaluation with commercial anti-inflammatories |
| Grantee: | Eduardo Maffud Cilli |
| Support Opportunities: | Regular Research Grants |